Side effects for people who took both medications included nausea and vomiting. Zepbound and Wegovy were compared in a ...

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

Eli Lilly's Zepbound surpassed Novo Nordisk's Wegovy in reducing waist circumference and overall weight loss in a recent ...

In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

A new study published in the New England Journal of Medicine comparing Eli Lilly’s Zepbound to Novo Nordisk ... in a statement that a similar dose of Wegovy led to greater weight loss in ...

Eli Lilly & Co.’s obesity drug Zepbound helped people trim about two inches more off their waists than Novo Nordisk A/S’s Wegovy in the first head-to-head study of the rival medicines.

Zepbound and Wegovy were compared in a head-to-head trial to show which weight loss drug was more effective for patients. This trial consisted of 751 people in the U.S. who were overweight or ...

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications.

A new study shows that people Zepbound lost about 50% more weight than those using Wegovy People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo ...